To determine if targeting the translation initiation machinery in NBs halts tumor growth, we evaluated the antitumor efficacies of two eIF4A inhibitors, rocaglamide and didesmethylrocaglamide62. This evidence concerns the gene EIF4A1 and neoplasm.